BioCentury
ARTICLE | Company News

Naurex, Allergan deal

September 21, 2015 7:00 AM UTC

Allergan completed its acquisition of Naurex for $560 million up front, plus undisclosed R&D success-based and sales-threshold milestone payments (see BioCentury, Aug. 3). ...